The Effect of The Plant Medicago Sativa On Diabetic Patients

Investigating The Effect of Hydroalcoholic Extract of Medicago Sativa On Biochemical Markers, Oxidative Stress And Inflammation In Patients With Type 2 Diabetes

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20250303064911N1

Enrollment

Registered

2025-03-21

Start date

2025-04-04

Completion date

Unknown

Last updated

2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes Mellitus. Type 2 diabetes mellitus with other specified complications

Interventions

Intervention 1: Intervention group: Recipient Of Metformin 1000 Mg (500 Mg Tablet Twice A Day) + Hydroalcoholic Extract Of Alfalfa Plant (400 Mg Capsule Three Times A Day For Two Months). Intervention

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Confirmation of Type 2 Diabetes Under Treatment With Metformin

Exclusion criteria

Exclusion criteria: Having Rheumatic Diseases And Lupus

Design outcomes

Primary

Measure	Time frame
Ferric Reducing Antioxidant Power. Timepoint: Before And Immediately After The Completion Of The Intervention. Method of measurement: Lab Kit.;Malondialdehyde. Timepoint: Before And Immediately After The Completion Of The Intervention. Method of measurement: Lab Kit.;Fasting Blood Sugar. Timepoint: Before And Immediately After The Completion Of The Intervention. Method of measurement: Lab Kit.;Hemoglobin A1c. Timepoint: Before And Immediately After The Completion Of The Intervention. Method of measurement: Lab Kit.;C-Reactive Protein. Timepoint: Before And Immediately After The Completion Of The Intervention. Method of measurement: Lab Kit.;Superoxide Dismutase. Timepoint: Before And Immediately After The Completion Of The Intervention. Method of measurement: Lab Kit.	—

Measure

Time frame

Ferric Reducing Antioxidant Power. Timepoint: Before And Immediately After The Completion Of The Intervention. Method of measurement: Lab Kit.;Malondialdehyde. Timepoint: Before And Immediately After The Completion Of The Intervention. Method of measurement: Lab Kit.;Fasting Blood Sugar. Timepoint: Before And Immediately After The Completion Of The Intervention. Method of measurement: Lab Kit.;Hemoglobin A1c. Timepoint: Before And Immediately After The Completion Of The Intervention. Method of measurement: Lab Kit.;C-Reactive Protein. Timepoint: Before And Immediately After The Completion Of The Intervention. Method of measurement: Lab Kit.;Superoxide Dismutase. Timepoint: Before And Immediately After The Completion Of The Intervention. Method of measurement: Lab Kit.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactZahra Rahami

Yasouj University of Medical Sciences

z.rahami.65@gmail.com+98 74 3323 5153

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026